Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rapamycin for Angiofibromas in TSC
NCT01526356Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- May 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sirolimus in facial angiofibroma, sponsored by UTHealth Houston. Started May 2012; status: completed.
02
Drugs
sirolimus
03
Conditions
facial angiofibroma
Beyond the preview
Go deeper on NCT01526356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526356.